Fruit Fly-A Microscopic Window Bridging Life Sciences and Human Disease Research
DOI:
https://doi.org/10.53469/wjimt.2023.06(06).05Keywords:
Drosophila Melanogaster, Biomedicine, Genome Manipulation Technology, Cross-Species ApplicationsAbstract
This article provides an in-depth exploration of the pivotal role that Drosophila melanogaster, commonly known as the fruit fly, plays in biomedicine. Originating as a genetic research model in the early 20th century, Drosophila has evolved into a preferred subject in genetics, developmental biology, and neurobiology. This study aims to comprehensively explore Drosophila's applications through a meticulous literature review, shedding light on its contributions to developmental biology, biochemistry, molecular biology, and neuroscience. In addition, this article explores and explains the intersection of modern technology and fruit fly research. This study found that remarkable progress in Drosophila genome manipulation technology has led to the development of unique techniques with cross-species applications, expanding its potential in various scientific domains. The groundbreaking milestone of its genome sequencing in contemporary times solidifies its position as a crucial model for comprehending human biology and disease processes.
References
G.M. Rubin, E.B. Lewis, A brief history of Drosophila's contributions to genome research, Science 287(5461) (2000) 2216-8.
M.D. Adams, The genome sequence of Drosophila melanogaster, Science 287(5461) (2000) 2185-95.
D. St Johnston, The art and design of genetic screens: Drosophila melanogaster, Nat Rev Genet 3(3) (2002) 176-88.
M.D. Adams, J.J. Sekelsky, From sequence to phenotype: reverse genetics in Drosophila melanogaster, Nat Rev Genet 3(3) (2002) 189-98.
E. Bier, R. Bodmer, Drosophila, an emerging model for cardiac disease, Gene 342(1) (2004) 1-11.
T.E. Lloyd, J.P. Taylor, Flightless flies: Drosophila models of neuromuscular disease, Ann N Y Acad Sci 1184 (2010) e1-20.
E. Bier, Drosophila, the golden bug, emerges as a tool for human genetics, Nat Rev Genet 6(1) (2005) 9-23.
Lewis, B. E., A gene complex controlling segmentation in Drosophila, Nature 276(5688) (1978) 565-70.
C. Nüsslein-Volhard, E. Wieschaus, Nusslein-Volhard, C.W.E. Mutations affecting segment number and polarity in Drosophila. Nature 287, 795-801, Nature 287(5785) (1980) 795-801.
Dom, Iacute, M. Nguez, Iacute, F. Casares, Organ specification–growth control connection: New in- sights from the Drosophila eye–antennal disc, Developmental Dynamics 232(3) (2005) 673–684.
J.A. Lengyel, D.D. Iwaki, It takes guts: the Drosophila hindgut as a model system for organogenesis, Developmental Biology 243(1) (2002) 1-19.
R.J. Konopka, S. Benzer, Konopka R, Benzer S. Clock mutants of Drosophila melanogaster. Proc Natl Acad Sci USA 68: 2112-2116, Proceedings of the National Academy of Sciences 68(9) (1971) 2112-2116.
E.Y. Kim, K. Bae, F.S. Ng, N.R.J. Glossop, P.E. Hardin, I. Edery, Drosophila CLOCK protein is under posttranscriptional control and influences light-induced activity, Neuron 34(1) (2002) 69-81.
C. Cirelli, D. Bushey, S. Hill, R. Huber, R. Kreber, B. Ganetzky, G. Tononi, Reduced sleep in Drosophila Shaker mutants, Nature 434(7037) (2005) 1087-92.
Hendricks, Joan, C., Sumei, Lu, Kume, Kazuhiko, Jerry, C.-P., Yin, Gender Dimorphism in the Role of cycle (BMAL1) in Rest, Rest Regulation, and Longevity in Drosophila melanogaster, Journal of Biological Rhythms (2003).
Y. Xu, R. Viswanatha, O. Sitsel, D. Roderer, H. Zhao, C. Ashwood, C. Voelcker, S. Tian, S. Raunser, N. Perrimon, M. Dong, CRISPR screens in Drosophila cells identify Vsg as a Tc toxin receptor, Nature 610(7931) (2022) 349-355.
C. Chola, J.V.B. Benifa, D.S. Guru, A.Y. Muaad, J. Hanumanthappa, M.A. Al-Antari, H. AlSalman, A.H. Gumaei, Gender Identification and Classification of Drosophila melanogaster Flies Using Machine Learning Techniques, Comput Math Methods Med 2022 (2022) 4593330.
J.P. Castro, C.M.A. Carareto, Drosophila melanogaster P transposable elements: mechanisms of transposition and regulation, Genetica 121(2) (2004) 107-118.
C. Gonzalez, Drosophila melanogaster: A model and a tool to investigate malignancy and identify new therapeutics, Nature Reviews Cancer 13(3) (2013).
T. Das, R. Cagan, Drosophila as a novel therapeutic discovery tool for thyroid cancer, Thyroid 20(7) (2010) 689.
L.F. Willoughby, T. Schlosser, S.A. Manning, J.P. Parisot, A.M. Brumby, An in vivo large-scale chemical screening platform using Drosophila for anti-cancer drug discovery, Disease Models and Mechanisms 6(2) (2012) 521-529.